Research and Markets has projected the global hemp derivatives market to grow at a CAGR of 19.7 per cent from 2021 to 2028.
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
Fortune Business Insights says the market will grow at a CAGR of 50.9 per cent from 2020 to 2027.
Synbiotic SE has acquired 50.1 per cent of Daniel Kruse’s cannabis group in what it has described as the most significant merger for the European cannabis...
An SEIS and EIS fund has been launched in the UK that will target the medical cannabis sector.
The company has confirmed it has received commitments to raise £5.5m in a share placement in the London market.
The report showed that tinctures and capsules had the most accurate advertising, while topicals had the biggest discrepancy.
Equinox has announced its intention to trade on the AIM market of the London Stock Exchange.
The GCI Summit gives global leaders the opportunity to network with the best minds in cannabis from 7 to 9 December, 2021.
The proceeds will accelerate its plans to build an international medical cannabis company.